MARKET NEWS

Spero Therapeutics Announces Initiation of Clinical Trial
MeiraGTx Enters Strategic Collaboration With Janssen
Hitachi Chemical to Acquire apceth Biopharma
Fortress Biotech Announces Strategic Partnership With Alexion
Evelo Biosciences Announces Dosing of First Patient in Investigator-Sponsored Phase 2a Clinical Trial
Dicerna Announces Dosing of First Volunteer in Phase 1 Clinical Trial

  FEATURED EDITORIAL

  COMPANY PROFILE

Gateway Analytical is an innovative analytical laboratory that specializes in providing expert testing services to the pharmaceutical, medical device, and materials science industries. Built with quality as our cornerstone and timeliness, and customer service as our core values, we are able to offer project turnaround in as fast as 24 hours in a GMP-compliant environment. Our new, fully equipped 8,000-sq-ft laboratory space features HEPA-filtered controlled environments, ISO 9001 and ISO 17025 accreditations, specialized sample preparation capabilities, and a dedicated space for handling cytotoxic drug materials. Gateway is able to provide industry leading materials analysis services tailored to support a variety of unique drug development projects. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Abbvie Logo

AbbVie’s Immunology Pipeline Will Protect it From Biosimilar Erosion

Although AbbVie is feeling the impact of Humira biosimilar launch in Europe, its strong immunology pipeline is likely to protect its hold on the plaque psoriasis (PsO) and rheumatoid arthritis (RA) markets, according to GlobalData, a leading data and analytics company.

First Oral Add-On Treatment to Insulin for Treatment of Certain Patients With Type 1 Diabetes

First Oral Add-On Treatment to Insulin for Treatment of Certain Patients With Type 1 Diabetes

The EMA’s human medicines committee (CHMP) has recommended for the first time an adjunct treatment to insulin in the form of a tablet for certain patients with type 1 diabetes mellitus.

ABITEC Corporation Launches New Versatile Excipient for Oral Dose Applications

ABITEC Corporation Launches New Versatile Excipient for Oral Dose Applications

ABITEC Corporation, a global manufacturer of specialty lipids, continues to develop products that meet the ever-evolving demands of the pharmaceutical industry.

PCI Pharma Services Announces Bottling Line Expansion to Support Customer Needs

PCI Pharma Services Announces Bottling Line Expansion to Support Customer Needs

PCI Pharma Services  recently announce the expansion of its bottling line capacity at its Commercial Packaging site in Rockford, IL.

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

February 13 – Injection Devices
February 20 – Formulation Development